Y. Zhai

发表

Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

F. Monsma, C. Foster, J. Lachowicz, 2001, The Journal of clinical investigation.

MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCV.

E. Asante-Appiah, M. Dwyer, A. Nomeir, 2018, Bioorganic & medicinal chemistry letters.

In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist.

B. Hawes, D. Seiffert, M. Chintala, 2015, European journal of pharmacology.

SCH 530348 Is a Novel Oral Antiplatelet Agent Selective for Protease‐Activated Receptor‐1 (PAR‐1) Receptor Subtype Without Partial Agonist Activity

J. Lachowicz, M. Chintala, S. Kurowski, 2009 .

The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.

Ping Chen, W. Greenlee, A. Stamford, 2014, Journal of medicinal chemistry.

Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development.

M. Dwyer, A. Nomeir, R. Mazzola, 2016, Bioorganic & medicinal chemistry letters.

Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors.

James I. Fells, E. Asante-Appiah, C. Coburn, 2016, Bioorganic & medicinal chemistry letters.

Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742.

E. Asante-Appiah, C. Coburn, M. Dwyer, 2016, Bioorganic & medicinal chemistry letters.

Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742.

E. Asante-Appiah, C. Coburn, M. Dwyer, 2016, Bioorganic & medicinal chemistry letters.

Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity.

James I. Fells, E. Asante-Appiah, C. Coburn, 2016, Bioorganic & medicinal chemistry letters.

Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.

B. Neustadt, N. Lindo, W. Greenlee, 2008, Bioorganic & medicinal chemistry letters.

Trinorsesquiterpenoids from Inula racemosa

K. Gao, Deng-Gao Zhao, Yan-Yan Ma, 2013 .

Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression

B. Neustadt, A. Stamford, R. Bertorelli, 2009, Journal of Pharmacology and Experimental Therapeutics.

WGA-coated yttrium oxide beads enable an imaging-based adenosine 2a receptor binding scintillation proximity assay suitable for high throughput screening.

J. Lachowicz, L. Howells, T. Turek-Etienne, 2004, Assay and drug development technologies.

Characterization of the Potent and Highly Selective A 2 A Receptor Antagonists Preladenant and SCH 412348 in Rodent Models of Movement Disorders and Depression

B. Neustadt, A. Stamford, R. Bertorelli, 2009 .

Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitors.

E. Asante-Appiah, C. Coburn, M. Dwyer, 2016, Bioorganic & medicinal chemistry letters.